Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer (scientific article published on 22 September 2011)

Insulin-like growth factor receptor 1 (IGF1R) gene copy number is associated with survival in operable non-small-cell lung cancer: a comparison between IGF1R fluorescent in situ hybridization, protein expression, and mRNA expression

Q33813730

Inhibition of cancer cell proliferation and metastasis by insulin receptor downregulation

Q33818935

Insulin receptor functionally enhances multistage tumor progression and conveys intrinsic resistance to IGF-1R targeted therapy

Q33934670

Molecular Analysis of Non–Small Cell Lung Cancer Identifies Subsets with Different Sensitivity to Insulin-like Growth Factor I Receptor Inhibition

Q34187898

Prediagnostic body-mass index, plasma C-peptide concentration, and prostate cancer-specific mortality in men with prostate cancer: a long-term survival analysis

Q34845451

Physical and functional interaction between polyoma virus middle T antigen and insulin and IGF-I receptors is required for oncogene activation and tumour initiation

Q34993028

Insulin receptor isoforms and insulin receptor/insulin-like growth factor receptor hybrids in physiology and disease.

Q35002762

The insulin receptor isoform exon 11- (IR-A) in cancer and other diseases: a review.

Q35622508

Insulin-like growth factor receptor 1 (IGF1R) expression and survival in surgically resected non-small-cell lung cancer (NSCLC) patients.

Q35994860

Phosphorylated epidermal growth factor receptor and cyclooxygenase-2 expression in localized non-small cell lung cancer

Q36717778

The emerging role of the insulin-like growth factor pathway as a therapeutic target in cancer

Q37075569

The insulin-like growth factor pathway in lung cancer

Q37231655

Expression of insulin receptor isoform A and insulin-like growth factor-1 receptor in human acute myelogenous leukemia: effect of the dual-receptor inhibitor BMS-536924 in vitro

Q37389178

The rationale and development of therapeutic insulin-like growth factor axis inhibition for lung and other cancers

Q37562558

The potential role of insulin-like growth factor receptor inhibitors in the treatment of advanced non-small cell lung cancer

Q37724259

Targeted therapy in non-small-cell lung cancer--is it becoming a reality?

Q37765472

Compensatory insulin receptor (IR) activation on inhibition of insulin-like growth factor-1 receptor (IGF-1R): rationale for cotargeting IGF-1R and IR in cancer

Q39647932

Insulin receptor isoform A and insulin-like growth factor II as additional treatment targets in human osteosarcoma.

Q39877535

Phosphorylated insulin-like growth factor-i/insulin receptor is present in all breast cancer subtypes and is related to poor survival.

Q39906003

Insulin receptor expression by human prostate cancers

Q39941083

Down-regulation of type I insulin-like growth factor receptor increases sensitivity of breast cancer cells to insulin.

Q40185322

In vitro and in vivo antitumor effects of the dual insulin-like growth factor-I/insulin receptor inhibitor, BMS-554417.

Q40333087

Discovery of an inhibitor of insulin-like growth factor 1 receptor activation: implications for cellular potency and selectivity over insulin receptor

Q42834919

Prognostic role of insulin-like growth factor receptor-1 expression in small cell lung cancer

Q43192989

Prediction of recurrence-free survival in postoperative non-small cell lung cancer patients by using an integrated model of clinical information and gene expression

Q44571511

Insulin receptor expression and clinical outcome in node-negative breast cancer

Q44857623

Phase II study of the anti-insulin-like growth factor type 1 receptor antibody CP-751,871 in combination with paclitaxel and carboplatin in previously untreated, locally advanced, or metastatic non-small-cell lung cancer.

Q45950196

Antitumor activity of GSK1904529A, a small-molecule inhibitor of the insulin-like growth factor-I receptor tyrosine kinase

Q46041903

Intracellular presence of insulin and its phosphorylated receptor in non-small cell lung cancer.

Q46781616

Disruption of the insulin-like growth factor type 1 receptor in osteoblasts enhances insulin signaling and action.

Q50678899

The role of insulin receptors and IGF-I receptors in cancer and other diseases

Q81238512

P433

issue

P407

language of work or name

English

Q1860

P921

main subject

lung cancer

Q47912

preproinsulin

Q7240673

P304

page(s)

2454-2465

P577

publication date

2011-09-22

P1433

published in

Cancer

Q326041

P1476

title

Prognostic impact of insulin receptor expression on survival of patients with nonsmall cell lung cancer

P478

volume

118

Reverse relations

cites work (P2860)

Q47246743	A 16-gene expression signature to distinguish stage I from stage II lung squamous carcinoma
Q90192600	A Cohort Study of Exposure to Antihyperglycemic Therapy and Survival in Patients with Lung Cancer
Q52682466	A Randomized Phase II Study of Metformin plus Paclitaxel/Carboplatin/Bevacizumab in Patients with Chemotherapy-Naïve Advanced or Metastatic Nonsquamous Non-Small Cell Lung Cancer.
Q28731874	A novel classification of lung cancer into molecular subtypes
Q37105231	A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors
Q36140955	Activation of insulin-like growth factor 1 receptor in patients with non-small cell lung cancer
Q42218166	Association of IGF1R polymorphisms with the development of HBV-related hepatocellular carcinoma
Q35123145	Differential expression of the insulin-like growth factor receptor among early breast cancer subtypes
Q35803926	Effects of metformin on survival outcomes of lung cancer patients with type 2 diabetes mellitus: a meta-analysis
Q61455101	Epithelial insulin receptor expression-prognostic relevance in colorectal cancer
Q47988612	Expression of small leucine-rich extracellular matrix proteoglycans biglycan and lumican reveals oral lichen planus malignant potential
Q99248451	Hyperinsulinaemia in cancer
Q44518083	IGF-1R and Bmi-1 expressions in lung adenocarcinoma and their clinicopathologic and prognostic significance
Q35103273	Increased IR-A/IR-B ratio in non-small cell lung cancers associates with lower epithelial-mesenchymal transition signature and longer survival in squamous cell lung carcinoma
Q33822523	Insulin receptor expression in clear cell renal cell carcinoma and its relation to prognosis
Q38883620	Insulin, insulin receptors, and cancer.
Q38663388	Insulin-like Growth Factor 1 Receptor Expression in Advanced Non-small-cell Lung Cancer and its Impact on Overall Survival
Q34568232	Insulin-like growth factor 1 receptor (IGF1R) expression and survival in operable squamous-cell laryngeal cancer
Q34501591	Insulin-like growth factor receptor 1 (IGF1R) expression and survival in non-small cell lung cancer patients: a meta-analysis.
Q53525637	Insulin-like growth factor-1 receptor is associated with better prognosis in classical Hodgkin's lymphoma: Correlation with MET expression.
Q37151297	Metformin Enhances the Therapy Effects of Anti-IGF-1R mAb Figitumumab to NSCLC.
Q36103093	Metformin use and its effect on survival in diabetic patients with advanced non-small cell lung cancer
Q47700884	Oncogenic activity of insulin in the development of non-small cell lung carcinoma
Q36922072	Overexpression of Insulin-like Growth Factor-1 Receptor Is Associated With Penile Cancer Progression
Q38395821	Phosphorylated insulin-like growth factor-1 receptor (pIGF1R) is a poor prognostic factor in brain metastases from lung adenocarcinomas
Q33599090	Prediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapy
Q39324387	Prognostic impact of Raf-1 and p-Raf-1 expressions for poor survival rate in non-small cell lung cancer
Q36066604	Prognostic implications of tumoral expression of insulin like growth factors 1 and 2 in patients with non-small-cell lung cancer
Q64898408	Prognostic value of IGF-1R in lung cancer: A PRISMA-compliant meta-analysis.
Q35153493	Survival of patients with stage IV lung cancer with diabetes treated with metformin
Q37650665	TGFBI expression is an independent predictor of survival in adjuvant-treated lung squamous cell carcinoma patients
Q35677049	Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancer
Q93118229	The expression of the insulin receptor in gastric cancer correlates with the HER2 status and may have putative therapeutic implications
Q37984217	The insulin and insulin-like growth factor receptor family in neoplasia: an update
Q26852910	The links between insulin resistance, diabetes, and cancer
Q49986742	The preoperative HbA1c level is an independent prognostic factor for the postoperative survival after resection of non-small cell lung cancer in elderly patients
Q37315146	The tobacco-specific carcinogen-operated calcium channel promotes lung tumorigenesis via IGF2 exocytosis in lung epithelial cells
Q26798408	Understanding the Key to Targeting the IGF Axis in Cancer: A Biomarker Assessment
Q55434033	[The targets research of non-small cell lung cancer targeted therapy].